Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China.

Su-Shan Luo Qilong JiangWenshuang ZengQinzhou WangZhang-Yu ZouYanyan YuDao-Jun HongQuantao ZengSong Tan Zhouao Zhang Xiaoyu Huang Xiuming GuoJing ChenZhongyan ZhaoShixiong HuangJian-Quan ShiYing ChenLei DuChong YanJianying XiJie SongChong-Bo Zhaonull null

Published in: Annals of clinical and translational neurology (2024)

This multicenter cohort study demonstrated the efficacy of efgartigimod in rapid control of gMG. Patients with MGAE or MC would benefit from efgartigimod treatment.

Keyphrases

myasthenia gravis
cross sectional
double blind
clinical trial
combination therapy
smoking cessation